Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
3 drugs for “Thalassemia”
Phase 3 3
- CTX001VERTEX PHARMACEUTICALS INCBeta-Thalassemia; Thalassemia
- EtavopivatNOVO NORDISK A SThalassemia
- Mitapivat matchedAGIOS PHARMACEUTICALS, INC.Transfusion-dependent Alpha-Thalassemia; Transfusion-dependent Beta-Thalassemia
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.